King Laboratories Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.70 M
- Company Age 11 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 0.94 M
- Revenue Growth -24.17%
- Profit Growth -23.82%
- Ebitda -182.18%
- Net Worth 5.27%
- Total Assets -13.47%
About King Laboratories
King Laboratories Private Limited (KLPL) is a Private Limited Indian Non-Government Company incorporated in India on 30 May 2013 and has a history of 11 years and eight months. Its registered office is in Srinagar, Jammu & Kashmir, India.
The Company is engaged in the Chemicals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.70 M.
The company currently has active open charges totaling ₹0.94 M.
Bhat Ahmad and Taslim Dar serve as directors at the Company.
Company Details
-
Location
Srinagar, Jammu & Kashmir, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U24100JK2013PTC003895
-
Company No.
003895
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
30 May 2013
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Jammu
Industry
Who are the key members and board of directors at King Laboratories?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Taslim Dar
|
Managing Director | 30-May-2013 | Current |
Board Members (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
|
Bhat Ahmad
|
Director | 30-May-2013 | Current |
Financial Performance of King Laboratories.
King Laboratories Private Limited, for the financial year ended 2017, experienced significant reduction in revenue, with a 24.17% decrease. The company also saw a substantial fall in profitability, with a 23.82% decrease in profit. The company's net worth moved up by a moderate rise of 5.27%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of King Laboratories?
In 2017, King Laboratories had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Datacorp It Solutions Private LimitedBhat Ahmad and Taslim Dar are mutual person
Charges (Loans)
₹0.94 M
₹0
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 0.09 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 05 Jun 2021 | Hdfc Bank Limited | ₹0.94 M | Open |
How Many Employees Work at King Laboratories?
Unlock and access historical data on people associated with King Laboratories, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of King Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped King Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.